Ancona brings extensive expertise leading and advising technology companies to aid Medisafe’s mission to improve the health and lives of people around the world through medication adherence

BOSTON, MA — December 4, 2017. Medisafe, the leading personalized mobile health platform for medication management with four million patient and caregiver registered users globally, announced today the appointment of Henry Ancona as Chairman of the Board. Mr. Ancona has over 30 years of operational leadership building global businesses for both large and small technology companies. As Chairman, Ancona leverages his diverse industry experience and expertise to provide insights on market approach and growth strategies.

“I am delighted to be joining Medisafe’s Board. As the top medication management application in the world, Medisafe improves patients’ lives by enabling them to take their medications when they need to,” said Ancona. “Medisafe also offers a suite of products to pharma, payors and others that boost adherence, help drive meaningful patient engagement, and provide near real-time analytics on patient behavior.”

Mr. Ancona brings a history of strategic and operational success to Medisafe. He serves as board member/chair, and executive advisor to companies in healthcare, B-to-B software and software-enabled B-to-C businesses. He currently serves as Board Chairman at Signiant, and Board member at BlueConic and at Verne Global. Ancona holds an MBA from Harvard Business School and BS and MS degrees from MIT in electrical engineering and computer science.

“We are thrilled to bring Henry onto our team,” said Medisafe CEO Omri Shor. “Henry’s wisdom and deep experience at the intersection of healthcare, technology, corporate governance, consumer interests and company growth will help Medisafe enhance our mission of improving and saving lives through medication adherence and intelligent empowerment.”